2nd Annual Digital Pharma Asia

Day 1 : Wed, 25 Sept 2019

08:00
Registration Starts & Morning Coffee

09:00
IBC Opening Address

09:05
Chairperson’s Opening Remarks


PLENARY SESSIONS


09:10
Pharma Transformation Keynote Address
Moving Pharma Closer to its Most Important Customer: How Digital Technology is Enabling Patient-Centricity

Ron Kamienchick, Senior Director, Digital Health, Head of Diagnostics and Personalized Medicine, Teva Pharmaceuticals, United States

10:00
Pharma Leadership Roundtable:
The Next Pharma Industry Priorities: Business, Technology, Regulatory Compliance and Leadership

  • Pharma landscape and evolving regulations
  • Revolutionising the pharma industry towards patient engagement
  • Capturing new revenue streams and markets
  • Leveraging on strategic partnerships and collaborations to drive growth
  • The shift towards value-based pricing
  • Embracing digital transformation – Challenges and opportunities in Asia

Panellists:
Ryan Li, Head of Commercial Innovation & Alliance, Market Access, MSD, China
Angela Deluca, Head of Project Planning & Innovation Department, Japan Development, AbbVie, Japan

Aung Myo, Vice President of Clinical Development & Medical Affairs, Tessa Therapeutics, Singapore
Sophia Huang, Head of Regulatory Submission Management & Planning Beijing, Bayer Healthcare Company Limited, China
Amitabh Mishra, President & Chief Technology Officer, Emcure Pharma, India

10.40
Morning Networking & Refreshment Break


2ND DIGITAL PHARMA SUMMIT 2019 COMMENCES
THE IMMEDIATE TRENDS


11:15
Chairperson’s Opening Remarks

11:20
Driving Digital Transformation In Pharma Through Tech Partnerships 

  • Novartis’ experience sharing on building partnerships between Big Pharma and health-tech startups in APAC
  • Key success factors for pharma-tech partnerships: Lessons learnt from developing relationships with tech companies
  • How to create a balanced business model which combine pharma’s strengths with those of tech partner’s?
  • Working lean and agile in a traditional environment

Miguel Rivera, Business Model Transformation Head, Asia Cluster, Novartis, Singapore

11:50
AI and Data Science in the Age of Patient-Centricity

  • What is AI, Machine Learning, Deep Learning and Data Science?
  • What is Patient-Centricity?
  • How can new technologies help doctors and patients?
  • What’s next? And how can we best prepare for the new age of AI and Data Science?

Prabhuram Krishnan, Regional Medical Director (Asia ex China) – Specialty Care, Ipsen Pharma, Singapore  

12:30
Case Study: 
The First And Only FDA-Approved Smart Inhaler, Teva’s Proair Digihaler

  • Experience sharing on developing and commercializing ProAir Digihaler
  • Global outlook for the Internet of Medical Things (IoMT) market
  • How is patient-generated health data shifting the landscape of clinical research?

Ron Kamienchick, Senior Director, Digital Health, Head of Diagnostics and Personalized Medicine, Teva Pharmaceuticals, United States

13:00
Networking Lunch


DRUG & DEVICE DEVELOPMENT


14:00
Case Study: 

Drug Manufacturer’s Perspectives On Accelerating Drug Development Through Digitalized Supply ChaiIn The Case Of AI & Blockchain Tech 

  • Driving pharma supply chain effectiveness with data-driven processes
  • Case Study on India Pharma’s problem with USFDA import alerts: How can digitalization improve regulatory compliance for pharma manufacturers?
  • Potential of Artificial Intelligence and Blockchain Tech for the next-generation supply chain

Amitabh Mishra, President & Chief Technology Officer, Emcure Pharma, India

14:30
Transforming Pharma R&D With Data And Analytics 

  • How can AI and data science improve clinical trial feasibility and speed up drug discovery?
  • Pharma future and agile innovation: Reframing the pharma approach to accelerate digital transformation and innovation

Paul Jacobs, Head of Innovation, Digitalising R&D, LEO Pharma, Denmark

15:00
Utilising Digital Biomarkers In Clinical Trials: Is This The Future Of Drug Development 

  • The state of digital biomarkers today: Where does the industry currently stand?
  • Using digital biomarkers and point of care devices to maximize the probability of success for clinical trials
  • Considerations when incorporating digital biomarkers into clinical trial designs
  • Collaboration between tech and healthcare as key to embrace patient engagement opportunities

Dr. Asad Abu Bakar Ali, Head of Singapore Imaging Biomarkers, Translational Biomarkers, MSD, Singapore

15:30
Afternoon Networking & Refreshment Break

16:00
Fireside Chat With Big Pharma:  
How Wearables, MHealth Applications And Remote Patient Monitoring Tech May Potentially Revolutionalise Drug Development? 

Moderator: 
Dr. Harish Dave, Co-founder and Chief Medical Officer, AUM Biosciences, Singapore

Speaker:
Angela Deluca, Head of Project Planning & Innovation Department, Japan Development, AbbVie, Japan

16:30
Designing Data-Driven Algorithms For Effective Drug Discovery And Biomedical Research 

  • Overview of A*STAR’s Computational Phenomics (CHiP-GIS) platform, and the benefits of an integrated computational platform for Pharma’s R&D and drug discovery
  • AI/Machine Learning (ML) for Drug Discovery— Current Efforts and Future Applications
  • Innovative data mining/ML approaches for large-scale genomic data analysis

Dr. Judice Koh, Computational Phenomics Platform Leader, Genome Institute of Singapore, A*STAR, Singapore


HCP & PATIENT ENGAGEMENT


17:00
Optimising Digital Engagement Tools To Rebuild Meaningful HCP Relationships 

  • How to target effectively key customer groups using AI and smart advertisements
  • Using chatbots to discuss with patients and doctors in a regulated and secured way
  • Leading the conversation leveraging telehealth solutions and delivery of our drugs
  • Increasing patient adherence to drugs mixing digital therapeutics and innovative commercial offers

Nicolas Bargas, ASEAN Omnichannel Lead, UpJohn, Pfizer, Singapore

17:30
Panel Discussion:
Patient Engagement In The Digital Age – Are We There Yet?

  • Key considerations for designing digital tools for patient engagement
  • How to balance technology and human touch in the patient experience?
  • How is the pharma business model changing with the advent of digital tech?
  • Going Beyond the Portal: Emerging technologies and tools for HCPs and patients
  • Opportunity for digital therapeutics in Asia, and key challenges

Moderator:
Dr. Shailendra Bajpai, Global Head of Disease Management and Key Stakeholder Engagement, China & Emerging Markets – Diabetes and Cardio-vascular, Sanofi, Singapore

Panellists:
Nicolas Bargas, ASEAN Omnichannel Lead, UpJohn, Pfizer, Singapore
Paul Jacobs, Head of Innovation, Digitalising R&D, LEO Pharma, Denmark
Priti Jauhari, Head of Supply Chain, Business Technology Leader, Asia-Pacific, Johnson & Johnson, Singapore
Dr. Sherry Wang, Assistant Vice President, Commercialization – MEDTECH, A*ccelerate, A*STAR, Singapore

18:00
Chairman’s Closing Remarks and Close of Conference

Day 2 : Thu, 26 Sept 2019

09:00
Chairperson’s Opening Remarks

Rei Lim, Regional Digital Marketer, AstraZeneca, Singapore


PHARMA – HEALTHCARE SYNERGIES


09:10
How Is Digitalisation Changing The Pharma – Healthcare Relationship? 

  • Data as key in transforming the care continuum
  • Investments in digital pharma
  • Use cases of AI and analytics improving clinical outcomes: Sanofi’s partnership updates with Google’s healthcare arm, Verily, on its virtual diabetes clinic project

Dr. Shailendra Bajpai, Global Head of Disease Management and Key Stakeholder Engagement, China & Emerging Markets – Diabetes and Cardio-vascular, Sanofi, Singapore

09:40
EHR And Data Collaboration With Pharma

  • DHA’s NABIDH (pulse) project: Digital collaboration and health information exchange between the private and public sector
  • Information governance and data sharing policies
  • Access to new therapies, clinical data, and patient support
  • How can Big Data help with devising evidence-based patient care?

Dr. Osama Elhassan, Head of e-Health Section at Health Data & Information Analysis Department, Dubai Health Authority, Dubai


ANALYTICS & MARKETING


10:10
Digital Engagement: Optimising The Hcp Customer Journey

  • Understanding multichannel touchpoints that shape the HCP customer engagement journey
  • Leveraging technology, data enablement and content strategy to create a connected customer experience

Sherlynn Tan, Healthcare Digital Success Director, APAC, Arkadin, Singapore

10:40
Morning Networking & Refreshment Break

11:20
Case Study:
Expanding Outreach To Emerging Markets By Leveraging On Analytics

Joel Fan, Senior Analyst, Digital Commerce, Global IT Digital Business, Medtronic, Singapore

11:50
How Digital Disrupts Pharma Marketing

  • APAC’s digital landscape in the pharma and healthcareindustry
  • Illustrations of digital campaigns
  • Lessons to be learned about social media and data usage in pharma

Rei Lim, Regional Digital Marketer, AstraZeneca, Singapore

12:30
Networking Lunch


E-COMMERCE AND SUPPLY CHAINS


13:30
Providing Value Beyond The Pill – Revolutionizing An Organization With Digital Transformation And E-Commerce

Jinny Nasrito Munoz, Head of E-Commerce (Asia Pacific, Latin America, Middle East, Africa), Mundipharma, Singapore
Chris Chen, Head of Consumer Healthcare – Southeast Asia, Mundipharma, Singapore

14:10
Case Study:

Experimenting with the Use of AI and Machine Learning for Demand and Sales Forecasting in OTC Supply Chains

Praveen Raman, Head of Technology, Consumer Healthcare, Southeast Asia, GSK, Singapore


THE NEXT FRONTIER


14:50
Afternoon Networking & Refreshment Break

15:30
Panel Discussion:

Pharma’s Digital Transformation Playbook For Success

  • Current challenges faced by the different functions in pharma
  • How has ML and other advanced analytics transformed current commercial strategies in pharma?
  • Pharma’s shift from product- to customer/patient-centricity
  • How to leverage on digitalisation to empower consumers and enhance customer engagement in pharma/healthcare?

Moderator:
Rei Lim, Regional Digital Marketer, AstraZeneca, Singapore

Panellists:
Prabhuram Krishnan, Regional Medical Director (Asia ex China) – Specialty Care, Ipsen Pharma, Singapore
Priya Nagarajan, Strategy & Projects, APAC, Bayer (Southeast Asia) Pte Ltd., Singapore
Joel Fan, Senior Analyst, Digital Commerce, Global IT Digital Business, Medtronic, Singapore

16:30
Chairperson’s Closing Remarks